A 48-year-old woman from Mumbai with a nosocomial urinary tract infection is found to have a carbapenem-resistant Acinetobacter baumannii. The organism shows resistance to imipenem and meropenem but remains susceptible to colistin. Which is the most appropriate confirmatory investigation to identify the mechanism of carbapenem resistance?

Explanation

## Carbapenem Resistance Mechanism Identification in A. baumannii **Key Point:** Carbapenem-resistant A. baumannii typically produces either serine carbapenemases (OXA-type, KPC) or metallo-beta-lactamases (MBL). The Carba NP test followed by EDTA-imipenem inhibition testing is the most appropriate sequential approach to differentiate these mechanisms. ### Diagnostic Algorithm for Carbapenem Resistance ```mermaid flowchart TD A[Carbapenem-Resistant Gram-Negative]:::outcome --> B[Carba NP Test]:::action B --> C{Positive?}:::decision C -->|Yes| D[Carbapenemase Producer]:::outcome C -->|No| E[Non-enzymatic Resistance]:::outcome D --> F[EDTA-Imipenem Inhibition Test]:::action F --> G{Inhibited by EDTA?}:::decision G -->|Yes| H[Metallo-beta-lactamase]:::outcome G -->|No| I[Serine Carbapenemase]:::outcome ``` ### Step-by-Step Approach **1. Carba NP Test (Rapid Screening)** - Detects carbapenemase activity phenotypically - Positive in <2 hours - Confirms enzymatic (carbapenemase-mediated) resistance - High sensitivity and specificity for A. baumannii **2. EDTA-Imipenem Inhibition Test (Mechanism Differentiation)** - **EDTA** (ethylenediaminetetraacetic acid) is a chelating agent that inhibits **metallo-beta-lactamases** (MBL) - If imipenem resistance is reversed by EDTA → **MBL producer** (e.g., VIM, IMP, NDM) - If imipenem resistance persists despite EDTA → **Serine carbapenemase** (e.g., OXA-48, KPC) **High-Yield:** In A. baumannii, OXA-type serine carbapenemases (especially OXA-23, OXA-24, OXA-58) are the most common cause of carbapenem resistance globally, followed by MBL producers. **Clinical Pearl:** The combination of Carba NP + EDTA-inhibition test provides both rapid detection and mechanism identification, guiding appropriate infection control and treatment decisions. ### Comparison Table: Carbapenem Resistance Detection Methods | Test | Detects | Time | Differentiates Mechanism | Best Use | |---|---|---|---|---| | **Carba NP** | Carbapenemase | <2 hrs | No | Rapid screening | | **EDTA-Imipenem** | MBL vs Serine | 18-24 hrs | Yes | Mechanism identification | | **Modified Hodge** | Carbapenemase | 18-24 hrs | No | Older reference method | | **DDD Test** | ESBL | 18-24 hrs | No | ESBL, not carbapenemase | **Mnemonic:** **Carba NP = Carbapenemase Numeric Phenotype** (rapid detection); **EDTA = Enzyme Differentiation Test for Acinetobacter** (serine vs metallo).